NEWS AND PODCASTS
neuro42 Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging
February 2024
​
"neuro42, Inc. (“neuro42” or the “Company”), a medical technology Company leading the innovation of MRI and robotics for brain related diagnosis and treatment, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its portable diagnostic MRI scanner."
Viz.ai, Hyperfine team up to add image-reading AI to bedside MRI scanners
July 26, 2022
​
"Hyperfine has developed a compact MRI brain scanner that can be wheeled directly to the point of care, while Viz.ai is churning out artificial intelligence algorithms that analyze imaging data to spot signs of stroke, pulmonary embolism and other life-threatening conditions."
Game changer: St. Michael’s is first hospital in Canada to acquire clinical portable MRI scanner
April 11, 2022
"St. Michael’s Hospital is the first hospital in Canada to acquire a portable Magnetic Resonance Imaging (MRI) scanner for patient care that can generate clinical images of the brain at the patient’s bedside, helping physicians answer critical questions and make decisions about treatment in a timelier manner."
Queen's University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities
February 16, 2022
​
"Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area."
Narrowing the Gap in Health Care Access
January 14, 2022
​
"When Queen’s researcher Omar Islam (Radiology) first encountered the Hyperfine portable MRI at an international radiology conference in 2019, he immediately realized the potential impact a plug-in magnetic resonance imaging device on wheels could have in remote communities across Canada."
Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada
December 9, 2021
​
"Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging MRI device, Swoop®, today announced the Health Canada licensing of Swoop as well as the commercial launch of the imaging system in Canada.”
Portable MRI provides life-saving information to doctors treating strokes
August 25, 2021
"When patients exhibit stroke symptoms, doctors must quickly make a life or death determination: Are their symptoms caused by a clot that can be treated with blood thinners or by bleeding in the brain, which may require surgery?"
Hyperfine’s Swoop Portable MRI System
June 7, 2021
"The Swoop™ system developed by Hyperfine Research is a first-of-its-kind portable, low-field magnetic resonance imaging (MRI) device for point-of-care settings such as intensive care units, emergency departments, mobile stroke units and resource-limited environments."
Hyperfine introduces world's first point-of-care MRI system at the American College of Emergency Physicians (ACEP) Scientific Assembly 2019
October 29, 2019
"Hyperfine Research Inc. is introducing the world's first low-cost, point-of-care (POC) magnetic resonance imaging (MRI) system at the American College of Emergency Physicians (ACEP) Scientific Assembly 2019."